Prevention and control measures for HIV infection and AIDS
Even though HIV is preventable through effective public health measures, the HIV epidemic persists largely unchanged in the countries of the European Union and European Economic Area (EU/EEA) – with around 30 000 newly reported diagnoses every year.
ECDC estimates that around 810 000 people are currently living with HIV in the EU/EEA – of which 122 000 (15%) are not aware of their infection.
If diagnosed and treated early enough, people can live long and healthy lives with HIV. To reach the estimated 15% who are not aware of their infection, Europe needs to increase efforts to promote and facilitate more testing for HIV. And link those diagnosed to care.
Response should be strengthened and tailored to each country’s specific needs in order to control the HIV epidemic in Europe. This includes implementation of targeted, evidence-based HIV prevention programmes for key populations who are most at risk but might not be reached by (or are not responding to) current interventions like men who have sex with men, people who inject drugs and migrants from countries with generalised epidemics.
Read more
Peer-Reviewed Publication
Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?
Peer-Reviewed Publication
Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men
Peer-Reviewed Publication
Country level homophobia and protective sexual health behaviours among HIV negative or untested men who have sex with men in 45 countries
Peer-Reviewed Publication
Ability to Monitor National Responses to the HIV Epidemic “Beyond Viral Suppression”: Findings From Six European Countries
Peer-Reviewed Publication
Reorienting health systems to care for people with HIV beyond viral suppression
Peer-Reviewed Publication
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
Publication
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
Peer-Reviewed Publication